9:00-9:10 WELCOME & INTRODUCTION
Antonio Álvarez Blanco, Hospital Clínico San Carlos, Madrid
Antonio Casado, Hospital Clínico San Carlos, Madrid
Gloria Marquina, Hospital Clínico San Carlos, Madrid
Claudia Valverde, Vall d'Hebron University Hospital, Barcelona
.
9:10-9:45 SESSION 1. FOCUSING ON OUR RESEARCHERS: AN OVERVIEW OF GEIS-BUESA GRANTS
9:15-9:25 And the winner is…
By Miquel Tarón.
9:25-9:30 Buesa 2024: new award.
9:30-9:40 Buesa 2022.
César Serrano team: Claudia Valverde. H Universitario Vall d´Hebrón. Barcelona
.
9:40-10:40 SESSION 2. SARCOMA SUBTYPE HIGHLITHED: TENOSYNOVIAL GIANT CELL TUMOR
Chairs: Lydia Mediavilla, General Univ. Gregorio Marañón, Madrid
Javier Martínez Trufero, Hospital Univ. Miguel Servet, Zaragoza
9:45-9:55. Interactive clinical case.
Laura Jiménez, Institut Català d'Oncologia, L'Hospitalet de Llobregat (Barcelona)
9:55-10:05 Pathology insights.
Empar Mayordomo, Hospital Politècnic i Universitari la Fe, Valencia
10:05-10:15 What´s the role of surgery?
Eduardo Ortiz, Hospital Universitario La Paz, Madrid
10:15-10:25 New treatment opportunities.
William Tap, Memorial Sloan Kettering Cancer Center, New York (New York), USA
10:25-10:40 Discussion
.
10:40-11:00 COFFEE BREAK
.
11:00-12:15 SESSION 3. LET’S IMPROVE: AYAS
Chairs: Cristina Mata, Hospital General Univ. Gregorio Marañón, Madrid
Javier Orcajo, Hospital General Univ. Gregorio Marañón, Madrid
11:05-11:15 AYAs: why are they different?
Lianne Haveman, Prisens Maxima Centrum, Utrecht, The Netherlands
11:15-11:25 AYAs unit: what you need to start.
Macarena González & Paula Pérez, Vall d'Hebron University Hospital, Barcelona
11:25-11:35 Research: Trespassing the age barrier with ACCELERATE.
Cristina Larrossa, Hospital Sant Joan de Déu, Esplugues de Llobregat (Barcelona)
11:35-11:45 Networking: EUROEWING CONSORTIUM. What we have learned.
Sandra Strauss, University College London, London, United Kingdom
11:45-11:55 There is no place like home.
Hilde Bøgseth, Oslo University Hospital, Oslo, Norway
11:55-12:15 Discussion.
.
12:15-13:10 SESSION 4. FOCUSING ON IMMUNOTHERAPY
Chairs: Fina Cruz, Hospital Universitario de Canarias, La Laguna (Tenerife)
José Alejandro Pérez Fidalgo, Hospital Clínico Universitario, Valencia
12:20-12:35 New approaches in other tumors.
Arjún Oberoi, Vall d'Hebrón University Hospital, Barcelona.
12:35-12:50 Cell therapy in Ewing sarcoma
Francesca Del Bufalo, Ospedale Pediatrico Bambino Gesù, Rome, Italy
12:50-13:10 Discussion
.
13:15-14:00 LUNCH BREAK
.
14:00-15:15 SESSION 5. ARE WE READY FOR DIFFERENT TREATMENTS?
Chairs: José Manuel Morales, Hospital Univ. Virgen del Rocío, Seville
Nadia Hindi, Hospital Universitario Fundación Jiménez Díaz, Madrid
14:05-14:15 Cryotherapy. Indications and experience
Xavier Buy, Institute Bergonie, Bordeaux, France
14:15-14:25 Oncothermia. Indications and experience.
Elisabeth Arrojo, INMOA, Madrid
14:25-14:35 Discussion
14:35-14:45 GIST: Robotic assistance in difficult locations.
Sandra Castro, Vall d'Hebrón University Hospital, Barcelona
14:45-14:55 WD-Liposarcoma: is medical treatment an option?
Robert Maki, Memorial Sloan Kettering Cancer Center, New York (New York), USA
14:55-15:15 Discussion.
.
15:15-16:10 SESSION 6. CHALLENGING ISSUES
Chairs: Iñigo San Miguel, Hospital Universitario de Cruces, Baracaldo (Vizcaya)
Javier Martín Broto, Hospital Universitario Fundación Jiménez Díaz, Madrid
José Manuel Asencio, Hospital General Universitario Gregorio Marañón, Madrid
15:20-15:30 Pathological entities outside WHO? Clinical case.
Luis Ortega, Hospital Clínico San Carlos, Madrid
15:30-15:40 Pathological insight
Paolo Dei Tos, University of Padua, Italy
15:40-15:50 The Oncologist point of view.
Shreyas Patel, MD Anderson Cancer Center, Houston (Texas), USA
15:50-16:10 Discussion
.
16:10-17:20 Coffee break
16:30-16:40 “Uncomfortable” locations: Axial skeleton. Are we ready? Clinical case + first vote
Irene Carrasco, Hospital Universitario Virgen del Rocío, Seville
16:40-16:50 The surgeon point of view.
Antonio Martín Benlloch, Dr. Peset University Hospital, Valencia
16:50-17:00 The Radiation Oncologist point of view.
Felipe Calvo, Clínica Universidad de Navarra, Madrid
17:00-17:10 The Oncologist point of view
Miguel Abreu, Portuguese Institute of Oncology, Porto, Portugal
17:10-17:20 Discussion
.
17:20-18:20 SESSION 7. THE PATIENT ́S VOICE
Chairs: Rosa Alvarez & Ma Angeles Sala
The importance of supportive treatment
17:25-17:35 A patient challenge. Miguel Angel Rubio.
17:35-17:45 Nutritional assessment. Elena Roura. Fundación Alicia. Barcelona
17:45-17:55 Pre-rehabilitation and exercise. Oscar Martínez Sánchez. Fundación Ricky Rubio. Barcelona.
17:55-18:05 Taking care of the caregiver. Jonathan Levit, Escuela de Cuidadores de Fundación "la Caixa", Barcelona
18:05-18:30 Discussion.
Discussants: Patients representatives VYDA, FMPJC, APSATUR, ASARGA, Asociación IKER, FEPNC
18:30-18:40 FAREWELL
Antonio Casado, Hospital Clínico San Carlos, Madrid
Gloria Marquina, Hospital Clínico San Carlos, Madrid
Claudia Valverde, Vall d'Hebron University Hospital, Barcelona
.
.
VENUE
HOSPITAL CLÍNICO SAN CARLOS
Pabellón San Carlos
C/ Manuel Bartolomé Cossío, s/n
28040 Madrid
DINNER
The dinner for all attendees will be held on 3rd October.
CONFIRMATION IS REQUIRED
LANGUAGE
Simultaneous translation English-Spanish will be provided.
REGISTRATIONS
• Before July, 15th: 330,58€ + 21% (Spanish VAT) = 400€
• From 15th July to September, 1st: 454,55€ + 21% (Spanish VAT) = 550€
• After September, 1st: 578,51€ + 21% (Spanish VAT) = 700€
SYMPOSIUM'S SECRETARIAT:
E-mail: Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo. · Tel.: 912 866 807
.
.
SPONSORS:
UNDER THE AUSPICES OF:
